All financial reports and presentations

Latest result publication:
Q3/2026

President and CEO Thomas Hinnerskov: Capturing lifecycle growth across our unique and large installed base
 

Everything we do at Valmet starts with one question: how can we help our customers become more competitive? In the third quarter, the trust they place in Valmet translated into strong demand: orders received increased 25 percent organically, while 
comparable EBITA reached a record level for a third quarter.

I am particularly pleased with our biomaterial services business, where orders grew 12 percent organically. Growth was broad-based across regions, service categories and business areas. The market developed in line with our earlier view that it was 
stabilizing.

Valmet has spent decades building a unique and large installed base around the world. In biomaterials, we have the largest installed base in the industry, representing a significant long-term growth opportunity. Our task is to serve our customers more 
broadly throughout the lifecycle of their assets. This builds deeper customer relationships and creates more recurring business for Valmet.

Biomaterial capital orders were also strong at EUR 552 million, including major project wins in China and Asia-Pacific. Customers choose Valmet for some of their largest and most critical investments, including in the world’s most competitive 
markets. This reflects their confidence in our technology and in Valmet as a long-term partner. Each win also strengthens our installed base for decades to come.

Process Performance Solutions delivered three percent organic order growth in a low-growth market, with a comparable EBITA margin of 20.2 percent. With Severn now part of Valmet, we have a broader offering and a larger market to serve. The integration is 
progressing according to plan.

Comparable EBITA increased by EUR 10 million to EUR 169 million, supported by the Severn acquisition and the efficiency and cost reduction actions we are taking under our Lead the Way strategy. This is progress, but not the destination.

By 2030, our target is to grow 5 percent organically and reach a 15 percent comparable EBITA margin. Together, these take us to a 20 percent return on capital employed. We earn these returns by helping our customers run their assets more reliably and 
efficiently throughout their lifecycle. When customers win, Valmet wins. That is how we create long-term value for our shareholders and opportunities for our people.

Our strategic review is progressing according to plan. We are in the process of evaluating whether separating Biomaterial Solutions and Services and Process Performance Solutions into two standalone publicly listed companies would create additional 
value for shareholders compared with the current combined structure. We will provide an update at the latest in connection with our Financial Statements Review for 2026.”